What to watch with AMH and skin aging?

The question of AMH (anti-Müllerian hormone) and skin aging is not supported by strong human evidence. AMH is a well-established marker of ovarian reserve and age-related decline in follicle count. An indirect link to skin aging is discussed via estrogen levels: declining AMH correlates with perimenopause, where estrogen drop contributes to collagen loss, reduced elasticity, and wrinkle formation. However, skin aging is multifactorial (UV exposure, genetics, lifestyle, oxidative stress). No prospective studies demonstrate AMH as an independent predictor of skin aging. Moreover, AMH is not typically included in skin aging or longevity panels; MyBody-X focuses on DNA markers like FOXO3 or NAD+ precursors with different evidence bases. To understand skin aging, one should look at clinical skin parameters (collagen, elasticity, glycation) and validated biomarkers like HbA1c or vitamin D. AMH remains primarily a fertility marker. Evidence: mechanistic, indirect, no strong human trial.